Bausch + Lomb Amends CEO Separation Agreement
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in
Forward-looking Statements
This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch + Lomb's filings with the
© 2022 Bausch & Lomb Incorporated or its affiliates.
|
Investor Contact: |
Media Contact: |
|
Arthur Shannon |
Lainie Keller |
|
(908) 927-1198 |
|
|
Allison Ryan |
|
|
(877) 354-3705 (toll free) |
|
|
(908) 927-0735 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch--lomb-amends-ceo-separation-agreement-301709347.html
SOURCE Bausch + Lomb Corporation
